Cancer Progression and Metastasis Lab
@jackstadt-lab.bsky.social
We study mechanisms of cancer progression and metastasis - focus on colorectal cancer
🚀 Don’t miss this great event! We’ll showcase our newest work on tackling metastatic colorectal cancer 🔬✨
November 3, 2025 at 8:15 PM
🚀 Don’t miss this great event! We’ll showcase our newest work on tackling metastatic colorectal cancer 🔬✨
Reposted by Cancer Progression and Metastasis Lab
An antibody-drug conjugate targeting Trop2 significantly improved survival outcomes compared with platinum-based chemotherapy in pretreated patients with EGFR-mutated NSCLC, a randomized trial from China found. #esmo25 @antoniopassaro.bsky.social
www.medpagetoday.com/meetingcover...
www.medpagetoday.com/meetingcover...
Trop2 Drug Extends Survival in EGFR-Mutated Lung Cancer
Antibody-drug conjugate cut risk for death by 40% versus platinum-based chemotherapy
www.medpagetoday.com
October 20, 2025 at 5:11 PM
An antibody-drug conjugate targeting Trop2 significantly improved survival outcomes compared with platinum-based chemotherapy in pretreated patients with EGFR-mutated NSCLC, a randomized trial from China found. #esmo25 @antoniopassaro.bsky.social
www.medpagetoday.com/meetingcover...
www.medpagetoday.com/meetingcover...
Wow, congartulations Anna! That is well deserved!!!
September 16, 2025 at 6:46 PM
Wow, congartulations Anna! That is well deserved!!!